Dr.Reddy's Laboratories Ltd (REDY.NS)
* Says got EIR from US FDA for formulations manufacturing facility at Duvvada, Vishakhapatnam
Nov 16 Reuters has documented at least 12 cases of prescient messages about major Indian companies being posted in private WhatsApp groups.
* Says launch of clofarabine injection in U.S. market Source text: http://bit.ly/2zBoR7i Further company coverage:
* DR REDDY'S LABORATORIES ANNOUNCES THE LAUNCH OF GENERIC AZACITIDINE FOR INJECTION IN THE CANADIAN MARKET
* Sept quarter consol net profit after tax 3.05 billion rupees versus 3.09 billion rupees last year
* STARTS COOPERATION WITH DR. REDDY'S LABORATORIES ON SALES IN NORTH AMERICA Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Oct 3 Indian shares rose over 1 percent on Tuesday and were headed for a third consecutive session of gains, as automakers such as Tata Motors Ltd surged after posting strong monthly sales, while Dr. Reddy's Laboratories jumped on the launch of a drug in its key U.S. market.
* Says gets EIR from U.S. FDA for formulation Srikakulam plant (SEZ) unit 1, Andhra Pradesh Source text - http://bit.ly/2wleXS9 Further company coverage:
* FDA completes audit of co's Telangana custom pharmaceutical services facility, technology development centre with no observations Source text: http://bit.ly/2hhsmbf Further company coverage:
* Says received an establishment inspection report (EIR) from US FDA for formulation Srikakulam plant Source text for Eikon: Further company coverage: